位置:首页 > 蛋白库 > DMRT2_HUMAN
DMRT2_HUMAN
ID   DMRT2_HUMAN             Reviewed;         561 AA.
AC   Q9Y5R5; B1ANC0; B9EGJ1; Q9NPG6; Q9NQR6;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 2.
DT   03-AUG-2022, entry version 167.
DE   RecName: Full=Doublesex- and mab-3-related transcription factor 2;
DE   AltName: Full=Doublesex-like 2 protein;
DE            Short=DSXL-2;
GN   Name=DMRT2; Synonyms=DSXL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=10332030; DOI=10.1093/hmg/8.6.989;
RA   Raymond C.S., Parker E.D., Kettlewell J.R., Brown L.G., Page D.C., Kusz K.,
RA   Jaruzelska J., Reinberg Y., Flejter W.L., Bardwell V.J., Hirsch B.,
RA   Zarkower D.;
RT   "A region of human chromosome 9p required for testis development contains
RT   two genes related to known sexual regulators.";
RL   Hum. Mol. Genet. 8:989-996(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Kidney;
RX   PubMed=10729224; DOI=10.1006/geno.2000.6120;
RA   Ottolenghi C., Veitia R., Barbieri M., Fellous M., McElreavey K.;
RT   "The human doublesex-related gene, DMRT2, is homologous to a gene involved
RT   in somitogenesis and encodes a potential bicistronic transcript.";
RL   Genomics 64:179-186(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=10857744; DOI=10.1006/geno.2000.6160;
RA   Calvari V., Bertini V., De Grandi A., Peverali G., Zuffardi O.,
RA   Ferguson-Smith M., Knudtzon J., Camerino G., Borsani G., Guioli S.;
RT   "A new submicroscopic deletion that refines the 9p region for sex
RT   reversal.";
RL   Genomics 65:203-212(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PRO-381.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcriptional activator that directly regulates early
CC       activation of the myogenic determination gene MYF5 by binding in a
CC       sequence-specific manner to the early epaxial enhancer element of it.
CC       Involved in somitogenesis during embryogenesis and somite development
CC       and differentiation into sclerotome and dermomyotome. Required for the
CC       initiation and/or maintenance of proper organization of the sclerotome,
CC       dermomyotome and myotome (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9Y5R5; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-18072054, EBI-716006;
CC       Q9Y5R5; Q08117-2: TLE5; NbExp=3; IntAct=EBI-18072054, EBI-11741437;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00070}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y5R5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y5R5-2; Sequence=VSP_041248, VSP_041249;
CC       Name=3;
CC         IsoId=Q9Y5R5-3; Sequence=VSP_041247;
CC   -!- TISSUE SPECIFICITY: Expressed in testis, kidney and skeletal muscle.
CC   -!- MISCELLANEOUS: [Isoform 2]: Produced by DMRT2 bicistronic transcripts
CC       (AF284223/AF284224) from non-overlapping reading frame, according to
CC       PubMed:10729224. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by DMRT2 bicistronic transcripts
CC       (AF284223/AF284224) from non-overlapping reading frame, according to
CC       PubMed:10729224. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the DMRT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF130729; AAD40475.1; -; mRNA.
DR   EMBL; AF284223; AAF86291.1; -; mRNA.
DR   EMBL; AF284223; AAF86292.1; -; mRNA.
DR   EMBL; AF284224; AAF86293.1; -; mRNA.
DR   EMBL; AF284224; AAF86294.1; -; mRNA.
DR   EMBL; AF284225; AAF86295.1; -; mRNA.
DR   EMBL; Y19052; CAB59891.1; -; mRNA.
DR   EMBL; AL358976; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58816.1; -; Genomic_DNA.
DR   EMBL; BC136493; AAI36494.1; -; mRNA.
DR   CCDS; CCDS6444.1; -. [Q9Y5R5-1]
DR   CCDS; CCDS6445.1; -. [Q9Y5R5-2]
DR   RefSeq; NP_001124337.1; NM_001130865.2. [Q9Y5R5-2]
DR   RefSeq; NP_006548.1; NM_006557.6. [Q9Y5R5-2]
DR   RefSeq; NP_870987.2; NM_181872.4. [Q9Y5R5-1]
DR   RefSeq; XP_011515989.1; XM_011517687.1. [Q9Y5R5-1]
DR   RefSeq; XP_011515992.1; XM_011517690.2. [Q9Y5R5-1]
DR   RefSeq; XP_011515996.1; XM_011517694.2. [Q9Y5R5-3]
DR   RefSeq; XP_016869702.1; XM_017014213.1. [Q9Y5R5-1]
DR   RefSeq; XP_016869703.1; XM_017014214.1. [Q9Y5R5-1]
DR   RefSeq; XP_016869704.1; XM_017014215.1. [Q9Y5R5-1]
DR   RefSeq; XP_016869705.1; XM_017014216.1.
DR   AlphaFoldDB; Q9Y5R5; -.
DR   SMR; Q9Y5R5; -.
DR   BioGRID; 115898; 4.
DR   ELM; Q9Y5R5; -.
DR   IntAct; Q9Y5R5; 2.
DR   STRING; 9606.ENSP00000371686; -.
DR   iPTMnet; Q9Y5R5; -.
DR   PhosphoSitePlus; Q9Y5R5; -.
DR   BioMuta; DMRT2; -.
DR   DMDM; 334302783; -.
DR   MassIVE; Q9Y5R5; -.
DR   PaxDb; Q9Y5R5; -.
DR   PeptideAtlas; Q9Y5R5; -.
DR   PRIDE; Q9Y5R5; -.
DR   Antibodypedia; 9092; 73 antibodies from 19 providers.
DR   DNASU; 10655; -.
DR   Ensembl; ENST00000259622.10; ENSP00000259622.6; ENSG00000173253.16. [Q9Y5R5-2]
DR   Ensembl; ENST00000358146.7; ENSP00000350865.2; ENSG00000173253.16. [Q9Y5R5-1]
DR   Ensembl; ENST00000382251.7; ENSP00000371686.3; ENSG00000173253.16. [Q9Y5R5-1]
DR   Ensembl; ENST00000382255.7; ENSP00000371690.3; ENSG00000173253.16. [Q9Y5R5-2]
DR   Ensembl; ENST00000412350.6; ENSP00000397494.2; ENSG00000173253.16. [Q9Y5R5-2]
DR   Ensembl; ENST00000635183.1; ENSP00000489226.1; ENSG00000173253.16. [Q9Y5R5-2]
DR   GeneID; 10655; -.
DR   KEGG; hsa:10655; -.
DR   MANE-Select; ENST00000358146.7; ENSP00000350865.2; NM_181872.6; NP_870987.2.
DR   UCSC; uc003zhb.5; human. [Q9Y5R5-1]
DR   CTD; 10655; -.
DR   DisGeNET; 10655; -.
DR   GeneCards; DMRT2; -.
DR   HGNC; HGNC:2935; DMRT2.
DR   HPA; ENSG00000173253; Tissue enhanced (kidney, lymphoid tissue, parathyroid gland).
DR   MIM; 604935; gene.
DR   neXtProt; NX_Q9Y5R5; -.
DR   OpenTargets; ENSG00000173253; -.
DR   PharmGKB; PA27382; -.
DR   VEuPathDB; HostDB:ENSG00000173253; -.
DR   eggNOG; KOG3815; Eukaryota.
DR   GeneTree; ENSGT00940000156282; -.
DR   HOGENOM; CLU_1224438_0_0_1; -.
DR   InParanoid; Q9Y5R5; -.
DR   OMA; YKFTIDR; -.
DR   OrthoDB; 897429at2759; -.
DR   PhylomeDB; Q9Y5R5; -.
DR   TreeFam; TF317837; -.
DR   PathwayCommons; Q9Y5R5; -.
DR   SignaLink; Q9Y5R5; -.
DR   BioGRID-ORCS; 10655; 12 hits in 1093 CRISPR screens.
DR   GenomeRNAi; 10655; -.
DR   Pharos; Q9Y5R5; Tbio.
DR   PRO; PR:Q9Y5R5; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9Y5R5; protein.
DR   Bgee; ENSG00000173253; Expressed in kidney epithelium and 115 other tissues.
DR   ExpressionAtlas; Q9Y5R5; baseline and differential.
DR   Genevisible; Q9Y5R5; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0061055; P:myotome development; IEA:Ensembl.
DR   GO; GO:2000287; P:positive regulation of myotome development; IEA:Ensembl.
DR   GO; GO:0014807; P:regulation of somitogenesis; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0007548; P:sex differentiation; IBA:GO_Central.
DR   Gene3D; 4.10.1040.10; -; 1.
DR   InterPro; IPR001275; DM_DNA-bd.
DR   InterPro; IPR036407; DM_DNA-bd_sf.
DR   InterPro; IPR026607; DMRT.
DR   PANTHER; PTHR12322; PTHR12322; 1.
DR   Pfam; PF00751; DM; 1.
DR   SMART; SM00301; DM; 1.
DR   SUPFAM; SSF82927; SSF82927; 1.
DR   PROSITE; PS40000; DM_1; 1.
DR   PROSITE; PS50809; DM_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Metal-binding; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation; Zinc.
FT   CHAIN           1..561
FT                   /note="Doublesex- and mab-3-related transcription factor 2"
FT                   /id="PRO_0000207048"
FT   DNA_BIND        123..170
FT                   /note="DM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00070"
FT   REGION          1..119
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          414..435
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        43..67
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        79..95
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..233
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10729224"
FT                   /id="VSP_041247"
FT   VAR_SEQ         210..226
FT                   /note="GYRPIPAETYVGGTFPL -> VLLGLFYSYYVYIMNHL (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:10332030,
FT                   ECO:0000303|PubMed:10729224, ECO:0000303|PubMed:10857744"
FT                   /id="VSP_041248"
FT   VAR_SEQ         227..561
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10332030,
FT                   ECO:0000303|PubMed:10729224, ECO:0000303|PubMed:10857744"
FT                   /id="VSP_041249"
FT   VARIANT         381
FT                   /note="A -> P (in dbSNP:rs3824419)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_067719"
FT   VARIANT         458
FT                   /note="E -> Q (in dbSNP:rs17641078)"
FT                   /id="VAR_067720"
FT   CONFLICT        329
FT                   /note="A -> G (in Ref. 2; AAF86292/AAF86294/AAF86295)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        372
FT                   /note="P -> H (in Ref. 2; AAF86292/AAF86294/AAF86295)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   561 AA;  61814 MW;  17D856C78EBB43CB CRC64;
     MADPQAGSAA GDWEIDVESL ELEEDVCGAP RSTPPGPSPP PADGDCEDDE DDDGVDEDAE
     EEGDGEEAGA SPGMPGQPEQ RGGPQPRPPL APQASPAGTG PRERCTPAGG GAEPRKLSRT
     PKCARCRNHG VVSCLKGHKR FCRWRDCQCA NCLLVVERQR VMAAQVALRR QQATEDKKGL
     SGKQNNFERK AVYQRQVRAP SLLAKSILEG YRPIPAETYV GGTFPLPPPV SDRMRKRRAF
     ADKELENIML EREYKEREML ETSQAAALFL PNRMVPGPDY NSYKSAYSPS PVEPPSKDFC
     NFLPTCLDLT MQYSGSGNME LISSNVSVAT TYRQYPLSSR FLVWPKCGPI SDTLLYQQCL
     LNATTSVQAL KPGASWDLKG ARVQDGLSAE QDMMPSKLEG SLVLPHTPEI QTTRSDLQGH
     QAVPERSAFS PPRRNFSPIV DTDSLAAQGH VLTKISKENT RHPLPLRHNP FHSLFQQTLT
     DKSGPELKTP FVKEAFEETP KKHRECLVKD NQKYTFTIDR CAKDLFVAKQ VGTKLSVNEP
     LSFSVESILK RPSSAITRVS Q
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024